Adverse events and complications are an inevitable aspect of cancer treatment, requiring meticulous management to ensure patient safety. Case studies often document unexpected reactions, such as immune-related adverse events from immunotherapy or severe neuropathy caused by chemotherapy. These instances underscore the importance of early detection and intervention, as well as individualized care to mitigate risks. For example, monitoring liver enzymes in patients receiving checkpoint inhibitors can prevent life-threatening toxicity. Sharing these cases enhances the oncology community’s understanding of managing complications, fostering the development of supportive care measures, updated treatment protocols, and innovative drug formulations with fewer side effects.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States